Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1998-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.ATV.18.4.655PMID 9555873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.

  1997cited by this paper
• Apolipoprotein E Inhibits Platelet Aggregation through the L-Arginine:Nitric Oxide Pathway

  1997cited by this paper
• Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII).

  1997cited by this paper
• Effects of short-term stanozolol administration on serum lipoproteins in hepatic lipase deficiency.

  1997cited by this paper
• Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE.

  1997cited by this paper
• Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models

  1996cited by this paper
• Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects.

  1996cited by this paper
• HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients.

  1995cited by this paper
• Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans.

  1995cited by this paper
• Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.

  1995cited by this paper
• Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.

  1995cited by this paper
• Generation of Pre-β1-HDL and Conversion Into α-HDL

  1995cited by this paper
• Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

  1995cited by this paper
• Generation of pre-beta 1-HDL and conversion into alpha-HDL. Evidence for disturbed HDL conversion in Tangier disease.

  1995cited by this paper
• High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

  1995cited by this paper
• Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.

  1994cited by this paper
• Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.

  1993cited by this paper
• Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

  1993cited by this paper
• Very low high-density lipoproteins without coronary atherosclerosis.

  1993cited by this paper
• Familial hypoalphalipoproteinemia in premature coronary artery disease.

  1993cited by this paper
• Familial HDL deficiency due to marked hypercatabolism of normal apoA-I.

  1993cited by this paper
• In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.

  1993cited by this paper
• Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasma.

  1993cited by this paper
• Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods.

  1993cited by this paper
• In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis.

  1992cited by this paper
• Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism.

  1992cited by this paper
• Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.

  1992cited by this paper
• Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.

  1991cited by this paper
• A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

  1991cited by this paper
• Differential tissue-specific expression of human apoA-I and apoA-II.

  1991cited by this paper
• High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.

  1990cited by this paper
• Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

  1990cited by this paper
• Apolipoprotein A-I metabolism in subjects with a PstI restriction fragment length polymorphism of the apoA-I gene and familial hypoalphalipoproteinemia.

  1990cited by this paper
• HDL Metabolism and Atherosclerosis

  1990cited by this paper
• Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100.

  1989cited by this paper
• Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

  1988cited by this paper
• In vivo metabolism of proapolipoprotein A-I in Tangier disease.

  1987cited by this paper
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

  1986cited by this paper
• Isolation and characterization of apolipoproteins A-I, A-II, and A-IV.

  1986cited by this paper
• Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I.

  1985cited by this paper
• High density lipoprotein metabolism.

  1984cited by this paper
• Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II.

  1984cited by this paper
• Biosynthesis of human preproapolipoprotein A-II.

  1983cited by this paper
• In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity.

  1983cited by this paper
• Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings.

  1983cited by this paper
• cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I.

  1983cited by this paper
• Human apolipoprotein A-I and A-II metabolism.

  1982cited by this paper
• Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

  1981cited by this paper
• Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals.

  1980cited by this paper
• Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.

  1978cited by this paper
• Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase.

  1977cited by this paper

• Effect of Linoleic Acid on Cholesterol Levels in a High-Fat Diet-Induced Hypercholesterolemia Rat Model

  2022cites this paper
• APOA1 Gene

  2020cites this paper
• Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins

  2020cites this paper
• ABCA1 Gene

  2020cites this paper
• Dyslipidemic Effect of Doxorubicin and Etoposide: A Predisposing Factor for theAntineoplastic Drugs-induced Cardiovascular Diseases

  2018cites this paper
• HDL genetic defects.

  2014cites this paper
• Adding MUFA to a dietary portfolio of cholesterol-lowering foods reduces apoAI fractional catabolic rate in subjects with dyslipidaemia

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

  2013cites this paper
• Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome

  2013cites this paper
• Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome

  2013cites this paper
• A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease.

  2013cites this paper
• Plant‐Derived Manufacturing of Apolipoprotein AIMilano: Purification and Functional Characterization

  2012cites this paper
• Dégradation des membres de la famille du LDLRpar la convertase PCSK9 : troisième locus de l'hypercholestérolémie familiale

  2011cites this paper
• Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis[S]

  2010cites this paper
• CHAPTER 7 – High-Density Lipoprotein Mutations

  2009cites this paper
• for High-Density Lipoprotein Lowering in Insulin Resistance and Hypertriglyceridemia Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles : A Mechanism

  2008cites this paper
• Statins and primary prevention: is all the evidence in?

  2008cites this paper
• Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.

  2008cites this paper
• Common variants in the ATP-binding cassette transporter 1 gene with decreased HDL-cholesterol levels and coronary artery disease.

  2008cites this paper
• Genetic disorders of HDL metabolism: from model to mechanism

  2008cites this paper
• Biologically active, non membrane‐anchored precursors – an overview

  2008cites this paper
• Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles: A Mechanism for High-Density Lipoprotein Lowering in Insulin Resistance and Hypertriglyceridemia

  2008cites this paper
• ATP-binding Cassette A1-mediated Lipidation of Apolipoprotein A-I Occurs at the Plasma Membrane and Not in the Endocytic Compartments*

  2008cites this paper
• [Familial HDL deficiency].

  2007cites this paper
• Genetic Etiology of Isolated Low HDL Syndrome: Incidence and Heterogeneity of Efflux Defects

  2007cites this paper
• Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans? Published, JLR Papers in Press, May 9, 2006.

  2006cites this paper
• Structure, function and amyloidogenic propensity of apolipoprotein A-I

  2006cites this paper
• Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48–Containing Lipoproteins in Humans

  2006cites this paper
• Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.

  2006cites this paper
• Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments Published, JLR Papers in Press, September 11, 2006.

  2006cites this paper
• New insights into the biogenesis of human high-density lipoproteins

  2006cites this paper
• Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux*

  2006cites this paper
• Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma Published, JLR Papers in Press, March 23, 2006.

  2006cites this paper
• High‐density lipoprotein apolipoprotein A‐I kinetics: comparison of radioactive and stable isotope studies

  2006cites this paper
• Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men.

  2005cites this paper
• High-density lipoprotein apolipoprotein A-I kinetics in obesity.

  2005cites this paper
• Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.M400477-JLR200

  2005cites this paper
• Chapter 82 – Tangier Disease and Neuropathy

  2005cites this paper
• Étude comparative de l'impact de la simvastatine et de l'atorvastatine, deux inhibiteurs de l'HMG-COA réductase, sur la cinétique in vivo de l'apolipoprotéine A-I chez l'homme

  2004cites this paper
• Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?

  2004cites this paper
• Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism Published, JLR Papers in Press, June 1, 2004. DOI 10.1194/jlr.M400090-JLR200

  2004cites this paper
• Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia.

  2004cites this paper
• Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.

  2004cites this paper
• Investigation du rôle des molécules de signalisation cellulaire dans la lipidation de l'apolipoprotéine A-I

  2004cites this paper
• Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter*

  2004cites this paper
• Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men: comparison of a low-fat diet and a high-monounsaturated fatty acid diet.

  2004cites this paper
• Molecular and Cellular Physiology of Apolipoprotein A-I Lipidation by the ATP-binding Cassette Transporter A1 (ABCA1)*

  2004cites this paper
• Expression of Human Hepatic Lipase in the Rabbit Model Preferentially Enhances the Clearance of Triglyceride‐Enriched Versus Native High‐Density Lipoprotein Apolipoprotein A‐I

  2003cites this paper
• Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.

  2003cites this paper
• Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles

  2003cites this paper
• Expression, regulation, and activity of ABCA1 in human cell lines.

  2003cites this paper
• Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol

  2003cites this paper
• Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles Published, JLR Papers in Press, March 1, 2003. DOI 10.1194/jlr.M200273-JLR200

  2003cites this paper
• High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study

  2002cites this paper
• ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease.

  2002cites this paper
• Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia DOI 10.1194/jlr.M100349-JLR200

  2002cites this paper
• Dynamics of reverse cholesterol transport: protection against atherosclerosis.

  2002cites this paper
• cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200235-JLR200

  2002cites this paper
• Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia DOI 10.1194/jlr.M200016-JLR200

  2002influential citation
• ABCA1Alabama: a novel variant associated with HDL deficiency and premature coronary artery disease

  2002cites this paper
• Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R).

  2001cites this paper
• Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts.

  2001cites this paper
• Impaired HDL response to fat in men with coronary artery disease.

  2000cites this paper
• Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.

  2000cites this paper
• Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.

  2000cites this paper
• Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.

  2000cites this paper
• Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

  2000influential citation
• Mutations due gene de l"ATP binding cassette-1 (ABC1) dans la maladie de Tangier et la deficience familiale en HDL

  2000cites this paper
• Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice.

  2000cites this paper
• Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency.

  1999cites this paper
• Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.

  1999cites this paper
• High Density Lipoproteins in Health and in Disease

  1999cites this paper
• Association of apolipoprotein E with α2-macroglobulin in human plasma

  1998cites this paper
• Association of apolipoprotein E with alpha2-macroglobulin in human plasma.

  1998cites this paper
• Genetics of lipoprotein disorders.

  1998cites this paper
• Studying Apolipoprotein Turnover with Stable Isotope Tracers: Correct Analysis Is by Modeling Enrichments Constant Tracee Flux Implies That Protein Amount Changes with Time

  year unknowncites this paper